Benefits: Tirzepatide: Dual-action with GLP-1 and GIP Potential for up to 22.5% weight loss Better appetite control and fat burning Supports blood sugar balance and reduces inflammation Semaglutide: Strong appetite suppression Sustainable Weight Loss (15%-20% weight loss) Helps regulate blood sugar and reduces diabetes risks Proven track record with many successful cases Which GLP-1 Weight Loss Medication is Right for You
Wegovy HDs approval, completed just 54 days after filing, highlights the speed of the pathway
This contrasts sharply with insurance-based pathways, where prior authorisation review, formulary restrictions, and pharmacy benefit processing extend timelines to 48 weeks on average
The comparison is understandable, but it needs careful wording
Glucagon-like peptide-1 receptor agonists (GLP1-RA) mimic the bodys natural GLP-1 hormone, enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and promoting satiety
Your healthcare provider will tailor the dosage and schedule based on blood tests and symptoms